Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 28, 2015 2:11 PM ET

Pharmaceuticals

Company Overview of SO Pharmaceutical Corporation

Company Overview

SO Pharmaceutical Corporation develops pharmaceutical products based on Solid in Oil Suspension technology. It develops oral and transcutaneous drugs, and consumer products; and improves the existing drugs. The company was founded in 2009 and is based in Kobe, Japan. As of January 31, 2011, SO Pharmaceutical Corporation operates as a subsidiary of cocokara fine Inc.

Kobe KIMEC Center Building 7F

1-5-2 Minatojima-minamimachi

Chuo-ku

Kobe,  650-0047

Japan

Founded in 2009

Phone:

81 7 8304 0950

Fax:

81 7 8304 0951

Key Executives for SO Pharmaceutical Corporation

Supreme Technical Adviser
Technical Advisor
Compensation as of Fiscal Year 2015.

Similar Private Companies By Industry

Company Name Region
serotec Co,.Ltd Asia
Teika Pharmaceutical Co., Ltd. Asia
Ajinomoto Pharmaceuticals Co.,Ltd. Asia
MSD K.K. Asia
Beacle, Inc. Asia

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SO Pharmaceutical Corporation, please visit www.so-pharma.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.